3D Cell Culture Assay Services Specializing in 3D cell culture assays, Visikol performs in vitro assays for drug screening and toxicity assessment using high content screening, confocal microscopy, ELISA, and other assays. arrow_rightHigh Content Screening arrow_rightAntibody Pharmacokinetics arrow_rightHepatotoxicity Screening arrow_rightImmune Cell Infiltration arrow_rightCancer Drug Screening Learn more Precision-Cut Liver Slices Our drug screening services using liver tissue obtained from human donors, precision-cut and cultured up to 96 hours for the assessment of therapeutic efficacy are the next best thing to a clinical trial. arrow_rightOverview arrow_rightStudy Formats arrow_rightEndpoints Learn more 3D Tissue Imaging and Analysis Using immunolabeling, tissue clearing, and confocal microscopy, we are able to transform tissues into three-dimensional data sets for sophisticated quantitative histological analysis. arrow_rightOur Approach arrow_rightImmunolabeling arrow_right3D Tissue Imaging arrow_right3D Image Analysis arrow_rightApplications Learn more Histology and Digital Pathology We help our Clients shift their histopathology analysis efforts from a qualitative, human-driven approach to a quantitative, digital approach. We have worked with clients on projects ranging from simple slide digitization and cell counting to developing custom-built, 21 CFR Part 11 compliant tissue classification algorithms and software for use in a clinical setting. arrow_rightSlide Scanning arrow_rightImmunohistochemistry arrow_rightCell Counting arrow_rightBiomarker Quantification arrow_rightImmuno-Oncology Learn more Image Analysis Turn your images into insights. Our team is comprised of experts in quantitative image analysis. Whether you have huge volumes of high content imaging data, whole slide histopathology images, or 3D confocal stacks, our team of experts can rapidly conduct quantitative analysis of your bio-imaging data. arrow_rightSlide Scanning arrow_rightImmunohistochemistry arrow_rightCell Counting arrow_rightBiomarker Quantification arrow_rightImmuno-Oncology Learn more 3D Cell Culture Models As experts in 3D cell culture model generation and assessment, we will find a model to match your needs. Visikol provides standardized and custom 3D cell culture models to clients that meet specific cost, throughput and bio-relevancy requirements. Learn more arrow_rightOverview arrow_rightImportance of 3D Models arrow_rightCustom Model Development arrow_rightOpenLiver HepaRG NP 3D Model arrow_rightOncology Models Custom Drug Discovery Solutions The Visikol team is comprised of experts in assay development, imaging, image analysis and advanced in vitro models. We can work with you to develop customized research programs to address the most complex drug discovery and development problems. We offer implementation services so clients can in-source our custom-developed assays. arrow_rightCustom Drug Discovery arrow_rightOur Approach arrow_rightHow we work with Clients Learn more
Visikol is a contract research organization that specializes in advanced drug discovery solutions including 3D cell culture assays and tissue imaging utilizing high content screening and confocal microscopy, as well as digital pathology and AI solutions for histological analysis of tissue sections. Since its inception in 2012, Visikol has developed a portfolio of tissue imaging and analysis technologies that allow for the transformation of tissues and cells into quantitative data sets that can be mined for actionable insights.
Advanced Drug Discovery
As a company, Visikol is focused on shifting the paradigm of how tissues and cells are analyzed from a qualitative human-driven approach to a quantitative computer vision driven approach. Visikol offers services to pharmaceutical and biotech clients to help them accelerate their drug discovery efforts and to reduce the translational gap between in vitro and in vivo studies through the use of advanced cell culture models and analysis techniques.
Visikol offers a wide range of assay formats and endpoints, please explore the top menu of our site to learn more about the range of assays we provide, or reach out directly to discuss how we can enhance your research. We also have worked with numerous clients to develop custom assays for use in specialized campaigns, and we offer implementation services for larger clients who wish to in-source our custom-built assays.
“I am very impressed with the thoroughness of the analysis. I hope to steer more data your way soon. Again, thank you for undertaking this at a small cost. It is much appreciated.”
Marie M., Palatin Technologies
“Thanks for getting this back so quickly, and for the thoroughness of the design and report. We look forward to working with you again!”
“A pleasure to work with. Concise and detailed report for our 3D cell assay. We’ll have more projects your way soon!”
“Extremely impressive work, thanks for getting this back to us so quickly. I really appreciate the detailed analysis.”
Drug discovery is the process by which potential new medicines are identified, repurposed and/or designed. This involves a wide range of scientific disciplines including, but not limited to, biology, chemistry, and pharmacology. With the [...]
Highlights 3D liver fibrosis models typically incorporate both hepatocytes and various non-parenchymal (NPC) populations. Stimulation of these models using TGFβ1 can induce a fibrosis-like effect whereby the stellate population is activated and begins [...]
Hampton, NJ – March 9th, 2021 – Visikol today announced its partnership with Bruker to use Bruker’s flagship MuVi SPIM CS Light-Sheet Microscopy platform to provide its clients with an even wider range of [...]
Visikol was originally founded as a products oriented company when it launched its Visikol® HISTO™ portfolio of reagents and kits over five years ago for 3D tissue imaging which have now been used by [...]
Pharma Tech Outlook acknowledges Visikol and how the company is leveraging its advanced imaging and 3D cell culture solutions to provide its Clients with best-in-class drug discovery solutions. In this post, Visikol Chief Science [...]
After completing the imaging process for your desired biological model, you may find that some of your images have artifacts that are likely not a part of the true signal you’re attempting to extract. [...]